Back

SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Medical therapy for acute heart failure and changing outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Roberto Tarantini

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Impact of in-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction
Ms M. Diez (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Evidence-based heart failure therapies at discharge of patients with acute coronary syndromes and reduced ejection fraction: Data from the ACSIS survey
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
Association between sex and efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency: an AFFIRM-AHF subgroup analysis
Professor G. Rosano (London, GB)
Abstract Slides Video
Presentation thumbnail
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry.
Professor P. Maury (Toulouse, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Medical therapy for acute heart failure and changing outcomes

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Presentation
Early hospital management
thumbnail
Congress Presentation
Acute and advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources